Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2331 | 2212 | 27.8 | 57% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1117 | 9232 | MALIGNANT HYPERTHERMIA//RYANODINE RECEPTOR//EXCITATION CONTRACTION COUPLING |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MALIGNANT HYPERTHERMIA | Author keyword | 348 | 65% | 15% | 333 |
2 | IN VITRO CONTRACTURE TEST | Author keyword | 130 | 97% | 2% | 36 |
3 | HYPERTHERMIA MALIGNANT | Author keyword | 93 | 88% | 2% | 44 |
4 | CENTRAL CORE DISEASE | Author keyword | 42 | 56% | 2% | 51 |
5 | MALIGNANT HYPERTHERMIA INVEST UNIT | Address | 32 | 88% | 1% | 15 |
6 | MH INVEST UNIT | Address | 31 | 92% | 1% | 12 |
7 | COMPLICATIONS MALIGNANT HYPERTHERMIA | Author keyword | 25 | 75% | 1% | 18 |
8 | RYR1 | Author keyword | 23 | 44% | 2% | 40 |
9 | MALIGNANT HYPERTHERMIA SUSCEPTIBILITY | Author keyword | 15 | 82% | 0% | 9 |
10 | RECEPTORS RYANODINE | Author keyword | 15 | 82% | 0% | 9 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CONTRACTURE TEST | 138 | 85% | 3% | 73 |
2 | CENTRAL CORE DISEASE | 130 | 45% | 10% | 215 |
3 | VITRO CONTRACTURE TEST | 118 | 84% | 3% | 64 |
4 | RYR1 GENE | 95 | 82% | 2% | 55 |
5 | HYPERPYREXIA | 80 | 65% | 3% | 77 |
6 | CHROMOSOME 19Q12 132 | 73 | 96% | 1% | 23 |
7 | SUSCEPTIBLE SWINE | 72 | 93% | 1% | 27 |
8 | MALIGNANT HYPERTHERMIA | 61 | 23% | 11% | 241 |
9 | RYANODINE RECEPTOR GENE | 58 | 41% | 5% | 111 |
10 | MALIGNANT HYPERTHERMIA SUSCEPTIBILITY | 39 | 45% | 3% | 64 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Malignant hyperthermia | 2007 | 128 | 92 | 86% |
Mutations in RYR1 in malignant hyperthermia and central core disease | 2006 | 199 | 113 | 89% |
Malignant hyperthermia: Excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects | 1996 | 195 | 311 | 73% |
Genetics and pathogenesis of malignant hyperthermia | 2000 | 173 | 139 | 81% |
Dantrolene - A review of its pharmacology, therapeutic use and new developments | 2004 | 158 | 70 | 59% |
Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group | 2010 | 28 | 4 | 100% |
Preparation of Modern Anesthesia Workstations for Malignant Hyperthermia-susceptible Patients A Review of Past and Present Practice | 2011 | 19 | 13 | 92% |
The Relationship Between Exertional Heat Illness, Exertional Rhabdomyolysis, and Malignant Hyperthermia | 2009 | 42 | 29 | 86% |
Malignant hyperthermia and central core disease: Disorders of Ca2+ release channels | 1998 | 124 | 154 | 64% |
DNA Testing for Malignant Hyperthermia: The Reality and the Dream | 2014 | 6 | 131 | 60% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MALIGNANT HYPERTHERMIA INVEST UNIT | 32 | 88% | 0.7% | 15 |
2 | MH INVEST UNIT | 31 | 92% | 0.5% | 12 |
3 | ANAESTHESIA BIOMED | 6 | 100% | 0.2% | 4 |
4 | MED EDUC CLIN | 5 | 55% | 0.3% | 6 |
5 | UNIT ANAESTHESIA | 4 | 22% | 0.8% | 17 |
6 | ANESTHESIA BIOMED | 4 | 75% | 0.1% | 3 |
7 | MALIGNANT HYPERTHERMIA | 4 | 75% | 0.1% | 3 |
8 | N AMER MALIGNANT HYPERTHERMIA REGISTRY | 4 | 75% | 0.1% | 3 |
9 | MH UNIT | 4 | 56% | 0.2% | 5 |
10 | BECP DBMS | 3 | 100% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000094512 | HALOTHANE GENE//PORK QUALITY//HALOTHANE GENOTYPE |
2 | 0.0000094167 | FENOVERINE//IDIOPATHIC HYPER CK EMIA//HYPERCKEMIA |
3 | 0.0000086745 | ANIMAL BLOOD GROUPS AND BIOCHEMICAL GENETICS//ALPHA PROTEASE INHIBITORS//ALPHA 1 BETA GLYCOPROTEIN |
4 | 0.0000082864 | NEMALINE MYOPATHY//CONGENITAL MYOPATHY//CENTRONUCLEAR MYOPATHY |
5 | 0.0000081579 | RYANODINE RECEPTOR//SARCOPLASMIC RETICULUM//EXCITATION CONTRACTION COUPLING |
6 | 0.0000062271 | EQUINE MOTOR NEURON DISEASE//POLYSACCHARIDE STORAGE MYOPATHY//ATYPICAL MYOPATHY |
7 | 0.0000051222 | NEUROLEPTIC MALIGNANT SYNDROME//CATATONIA//MALIGNANT CATATONIA |
8 | 0.0000045084 | PERIODIC PARALYSIS//THYROTOXIC PERIODIC PARALYSIS//HYPOKALEMIC PERIODIC PARALYSIS |
9 | 0.0000040633 | MUSCULAR DYSGENESIS//POTASSIUM CONTRACTURES//INTRAMEMBRANE CHARGE MOVEMENT |
10 | 0.0000040027 | COMPLICATIONS MYALGIA//CADMIUM INDUCED HYPERTENSION//SUCCINYLCHOLINE |